Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease

Neurobiology of Aging

Volumn 27, Issue 5, 2006, Pages 773.e1-773.e3

  Tedde, Andrea ^a   Rotondi, Mario ^a   Cellini, Elena ^a   Bagnoli, Silvia ^a   Muratore, Laura ^a   Nacmias, Benedetta ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol 24S hydroxylase; Genetic factors; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; CYSTEINE; CYTOCHROME P450; CYTOCHROME P450 CYP46; THREONINE; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HUMAN; INTRON; MALE; ONSET AGE; PRIORITY JOURNAL;

EID: 33645975169     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.03.029     Document Type: Article

References (9)

1. Borroni B., Archetti S., Agosti C., Akkawi N., Brambilla C., Caimi L., et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25 (2004) 695-829
2. Desai P., DeKosky S.T., and Kamboh M.I. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neurosci Lett 328 (2002) 9-12
3. Johansson A., Katzov H., Zetterberg H., Feuk L., Johansson B., Bogdanovic N., et al. Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ-42 levels in Alzheimer's disease. Hum Genet 114 (2004) 581-587
4. Kabbara A., Payet N., Cottel N., Frigard B., Amouyel P., and Lambert J.C. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population. Neurosci Lett 363 (2004) 139-143
5. Kolsch H., Lutjohann D., Ludwig M., Schulte A., Ptok U., Jessen F., et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7 (2002) 899-902
6. Michikawa M. The role of cholesterol in pathogenesis of Alzheimer's disease: dual metabolic interaction between amyloid beta-protein and cholesterol. Mol Neurobiol 27 (2003) 1-12
7. Papassotiropoulos A., Streffer J.R., Tsolaki M., Schmid S., Thal D., Nicosia F., et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60 (2003) 29-35
8. Wolozin B. Cyp46 (24S-cholesterol hydroxylase): a genetic risk factor for Alzheimer disease. Arch Neurol 60 (2003) 16-18
9. Wood W.G., and Igbavboa U. Cholesterol trafficking and amyloid beta peptides. Pharmacopsychiatry Suppl. 2 (2003) S144-S148